You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


FDA panel OK’s Pfizer/BioNTech jab for children aged five to 11

After meeting yesterday to discuss recommending Pfizer/BioNTech’s COVID-19 vaccine for use in a younger population, the US Food and Drug Administration (FDA)’s Vaccines and Related Biological Products Advisory Committee have adopted a positive opinion on the vaccine for children aged five years and up.